Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPI: Difference between FV1 and FV2

Peter van Doorn, Jan Rosing, Connie Duckers, Tilman M. Hackeng, Paolo Simioni, Elisabetta Castoldi*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1194-1202
Number of pages9
JournalThrombosis and Haemostasis
Volume118
Issue number7
DOIs
Publication statusPublished - 1 Jul 2018

Keywords

  • factor V
  • tissue factor pathway inhibitor
  • R2 haplotype
  • thrombin generation
  • phospholipids
  • FACTOR PATHWAY INHIBITOR
  • TISSUE FACTOR PATHWAY
  • ACTIVATED PROTEIN-C
  • VENOUS THROMBOSIS
  • FACTOR-XA
  • COFACTOR ACTIVITY
  • COAGULATION
  • ALPHA
  • PROTHROMBINASE
  • RISK

Cite this